| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Endocrinology, Vol 10, 499-507, Copyright © 1996 by Endocrine Society
ARTICLES |
C Patrone, ZQ Ma, G Pollio, P Agrati, MG Parker and A Maggi
Milano Molecular Pharmacology Laboratory, Institute of Pharmacological Sciences, University of Milan, Italy.
Insulin is a well known mitotic agent for neuroblastoma cells. Human SK- N-BE neuroblastoma cells stably transfected with the estrogen receptor, however, undergo growth arrest and differentiation when treated with insulin. These effects were shown to be due to an insulin-dependent activation of the unliganded estrogen receptor. Here, we demonstrate that this activation involves the AF-2 COOH-terminal domain of the estrogen receptor and that the communication between estrogen and insulin receptor systems occurs via selected and specific transduction signals. In fact, by the use of dominant negative and dominant positive mutants we demonstrate that p21ras is essential for insulin and estrogen receptor coupling. With pharmacological tools, we prove that PI 3'kinase does not contribute to this cross-talk and that protein kinase C triggers transduction signals that act in synergism with p21ras. These results prove the intricacy of all these intracellular paths of communication. The finding that, in neuroblastoma cells, selected signal transduction systems are involved in the insulin- dependent activation of estrogen receptor is of particular interest considering that estrogen receptor might restrict the role played by insulin during the differentiation of neural cells and interfere with its proliferative potential while allowing its regulation of other functions related to cell survival.
This article has been cited by other articles:
![]() |
P. Mendez and L. M. Garcia-Segura Phosphatidylinositol 3-Kinase and Glycogen Synthase Kinase 3 Regulate Estrogen Receptor-Mediated Transcription in Neuronal Cells Endocrinology, June 1, 2006; 147(6): 3027 - 3039. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Blaustein Minireview: Neuronal Steroid Hormone Receptors: They're Not Just for Hormones Anymore Endocrinology, March 1, 2004; 145(3): 1075 - 1081. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Quesada and A. M. Etgen Functional Interactions between Estrogen and Insulin-Like Growth Factor-I in the Regulation of alpha 1B-Adrenoceptors and Female Reproductive Function J. Neurosci., March 15, 2002; 22(6): 2401 - 2408. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Gray, F. F. Bartol, B. J. Tarleton, A. A. Wiley, G. A. Johnson, F. W. Bazer, and T. E. Spencer Developmental Biology of Uterine Glands Biol Reprod, November 1, 2001; 65(5): 1311 - 1323. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nilsson, S. Makela, E. Treuter, M. Tujague, J. Thomsen, G. Andersson, E. Enmark, K. Pettersson, M. Warner, and J.-A. Gustafsson Mechanisms of Estrogen Action Physiol Rev, October 1, 2001; 81(4): 1535 - 1565. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Demay, M. De Monti, C. Tiffoche, C. Vaillant, and M. L. Thieulant Steroid-Independent Activation of ER by GnRH in Gonadotrope Pituitary Cells Endocrinology, August 1, 2001; 142(8): 3340 - 3347. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Aranda and A. Pascual Nuclear Hormone Receptors and Gene Expression Physiol Rev, July 1, 2001; 81(3): 1269 - 1304. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Smith, R. G. Wolford, T. B. ONeill, and G. L. Hager Characterization of Transiently and Constitutively Expressed Progesterone Receptors: Evidence for Two Functional States Mol. Endocrinol., July 1, 2000; 14(7): 956 - 971. [Abstract] [Full Text] |
||||
![]() |
A. V. Lee, J. G. Jackson, J. L. Gooch, S. G. Hilsenbeck, E. Coronado-Heinsohn, C. K. Osborne, and D. Yee Enhancement of Insulin-Like Growth Factor Signaling in Human Breast Cancer: Estrogen Regulation of Insulin Receptor Substrate-1 Expression in Vitro and in Vivo Mol. Endocrinol., May 1, 1999; 13(5): 787 - 796. [Abstract] [Full Text] |
||||
![]() |
M. Singh, G. Setalo Jr, X. Guan, M. Warren, and C. D. Toran-Allerand Estrogen-Induced Activation of Mitogen-Activated Protein Kinase in Cerebral Cortical Explants: Convergence of Estrogen and Neurotrophin Signaling Pathways J. Neurosci., February 15, 1999; 19(4): 1179 - 1188. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Chen, P. E. Pace, R. C. Coombes, and S. Ali Phosphorylation of Human Estrogen Receptor alpha by Protein Kinase A Regulates Dimerization Mol. Cell. Biol., February 1, 1999; 19(2): 1002 - 1015. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Rider, B. F. Kimler, and W. M. Justice Progesterone-Growth Factor Interactions in Uterine Stromal Cells Biol Reprod, July 1, 1998; 59(3): 464 - 469. [Full Text] |
||||
![]() |
C. Patrone, E. Gianazza, S. Santagati, P. Agrati, and A. Maggi Divergent Pathways Regulate Ligand-Independent Activation of ER{alpha} in SK-N-BE Neuroblastoma and COS-1 Renal Carcinoma Cells Mol. Endocrinol., June 1, 1998; 12(6): 835 - 841. [Abstract] [Full Text] |
||||
![]() |
V. Budhram-Mahadeo, M. Parker, and D. S. Latchman POU Transcription Factors Brn-3a and Brn-3b Interact with the Estrogen Receptor and Differentially Regulate Transcriptional Activity via an Estrogen Response Element Mol. Cell. Biol., February 1, 1998; 18(2): 1029 - 1041. [Abstract] [Full Text] |
||||
![]() |
S. Santagati, E. Gianazza, P. Agrati, E. Vegeto, C. Patrone, G. Pollio, and A. Maggi Oligonucleotide Squelching Reveals the Mechanism of Estrogen Receptor Autologous Down-Regulation Mol. Endocrinol., June 1, 1997; 11(7): 938 - 949. [Abstract] [Full Text] |
||||
![]() |
M. R. Walters, M. Dutertre, and C. L. Smith SKF-82958 Is a Subtype-selective Estrogen Receptor-alpha (ERalpha ) Agonist That Induces Functional Interactions between ERalpha and AP-1 J. Biol. Chem., January 11, 2002; 277(3): 1669 - 1679. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |